Breaking News Instant updates and real-time market news.

ERJ

Embraer

$15.72 /

+2.09 (+15.33%)

06:36
06/11/21
06/11
06:36
06/11/21
06:36

Embraer upgraded to Buy at BofA on 'significant' eVTOL opportunity

As previously reported, BofA analyst Ronald Epstein upgraded Embraer to Buy from Neutral with a price target of $20, up from $8. Electric vertical takeoff and landing, or eVTOL, aircraft are currently one of the "hottest" urban mobility innovations and the addressable market could be about $1T worldwide by 2040, contends Epstein. Given Embraer's know-how on developing aircraft on budget and on schedule, existing relationship with regional airlines, and worldwide ops for production and maintenance, he sees Embraer's Eve unit as being in a strong position in this nascent market, Epstein said. After Embraer announced it was in talks to merge Eve Urban Air Mobility with Zanite Acquisition Corp. in a tentative deal that would value the eVTOL unit at approximately $2B, the analyst said he sees "significant upside" from Eve's potential public listing or alternative investment opportunities.

ERJ Embraer
$15.72 /

+2.09 (+15.33%)

06/11/21 BofA
Embraer upgraded to Buy from Neutral at BofA
03/23/21 JPMorgan
Embraer price target raised to $13.50 from $9.50 at JPMorgan
08/11/20
Fly Intel: Top five analyst downgrades
08/11/20 Morgan Stanley
Embraer downgraded to Underweight from Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

Hot Stocks
Cerecor divests non-core neurology pipeline assets to Alto Neuroscience, ES » 07:33
06/23/21
06/23
07:33
06/23/21
07:33
CERC

Cerecor

$3.50 /

-0.085 (-2.37%)

Cerecor announces that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CERC Cerecor
$3.50 /

-0.085 (-2.37%)

CERC Cerecor
$3.50 /

-0.085 (-2.37%)

06/04/21 Cantor Fitzgerald
Cerecor initiated with an Overweight at Cantor Fitzgerald
04/21/21 Maxim
Cerecor upgraded to Buy from Hold at Maxim
04/21/21 Maxim
Cerecor upgraded to Buy from Hold at Maxim
04/20/21 Jefferies
Cerecor initiated with a Buy at Jefferies
CERC Cerecor
$3.50 /

-0.085 (-2.37%)

  • 08
    Jan
CERC Cerecor
$3.50 /

-0.085 (-2.37%)

Hot Stocks
Cerecor licenses immune checkpoint program from Sanford Burnham Prebys » 07:33
06/23/21
06/23
07:33
06/23/21
07:33
CERC

Cerecor

$3.50 /

-0.085 (-2.37%)

Cerecor announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CERC Cerecor
$3.50 /

-0.085 (-2.37%)

CERC Cerecor
$3.50 /

-0.085 (-2.37%)

06/04/21 Cantor Fitzgerald
Cerecor initiated with an Overweight at Cantor Fitzgerald
04/21/21 Maxim
Cerecor upgraded to Buy from Hold at Maxim
04/21/21 Maxim
Cerecor upgraded to Buy from Hold at Maxim
04/20/21 Jefferies
Cerecor initiated with a Buy at Jefferies
CERC Cerecor
$3.50 /

-0.085 (-2.37%)

  • 08
    Jan
CERC Cerecor
$3.50 /

-0.085 (-2.37%)

Hot Stocks
Heat Biologics to expand R&D facilities in Morrisville, North Carolina » 07:32
06/23/21
06/23
07:32
06/23/21
07:32
HTBX

Heat Biologics

$6.93 /

+0.01 (+0.14%)

Heat Biologics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HTBX Heat Biologics
$6.93 /

+0.01 (+0.14%)

HTBX Heat Biologics
$6.93 /

+0.01 (+0.14%)

05/06/21 Alliance Global Partners
Heat Biologics price target lowered to $32 from $40 at Alliance Global Partners
03/02/21 Cantor Fitzgerald
Heat Biologics initiated with an Overweight at Cantor Fitzgerald
02/09/21 Alliance Global Partners
Heat Biologics price target raised to $40 from $5 at Alliance Global Partners
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
HTBX Heat Biologics
$6.93 /

+0.01 (+0.14%)

HTBX Heat Biologics
$6.93 /

+0.01 (+0.14%)

HTBX Heat Biologics
$6.93 /

+0.01 (+0.14%)

Recommendations
Vroom price target raised to $47 from $43 at Jefferies » 07:32
06/23/21
06/23
07:32
06/23/21
07:32
VRM

Vroom

/

+

Jefferies analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
/

+

VRM Vroom
/

+

05/13/21 Raymond James
Vroom price target raised to $53 from $47 at Raymond James
05/13/21 JMP Securities
Vroom price target raised to $55 from $48 at JMP Securities
05/13/21 Piper Sandler
Vroom price target lowered to $58 from $60 at Piper Sandler
04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
VRM Vroom
/

+

  • 07
    Dec
  • 11
    Sep
VRM Vroom
/

+

VRM Vroom
/

+

VRM Vroom
/

+

Recommendations
Carvana price target raised to $400 from $375 at Jefferies » 07:32
06/23/21
06/23
07:32
06/23/21
07:32
CVNA

Carvana

$313.03 /

+17.26 (+5.84%)

Jefferies analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$313.03 /

+17.26 (+5.84%)

CVNA Carvana
$313.03 /

+17.26 (+5.84%)

04:52 Today JPMorgan
Carvana downgraded to Neutral from Overweight at JPMorgan
06/17/21 Baird
Carvana price target raised to $335 from $325 at Baird
06/10/21 Cantor Fitzgerald
Shift initiated with an Overweight at Cantor Fitzgerald
05/26/21 RBC Capital
Carvana initiated with an Outperform at RBC Capital
CVNA Carvana
$313.03 /

+17.26 (+5.84%)

  • 02
    Dec
CVNA Carvana
$313.03 /

+17.26 (+5.84%)

CVNA Carvana
$313.03 /

+17.26 (+5.84%)

CVNA Carvana
$313.03 /

+17.26 (+5.84%)

Recommendations
Scotts Miracle-Gro price target lowered to $250 from $305 at Raymond James » 07:30
06/23/21
06/23
07:30
06/23/21
07:30
SMG

Scotts Miracle-Gro

$196.83 /

+2.465 (+1.27%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMG Scotts Miracle-Gro
$196.83 /

+2.465 (+1.27%)

SMG Scotts Miracle-Gro
$196.83 /

+2.465 (+1.27%)

05/06/21 Truist
Scotts Miracle-Gro price target raised to $300 from $275 at Truist
04/09/21 Truist
Scotts Miracle-Gro price target raised to $275 from $270 at Truist
04/09/21 Raymond James
Scotts Miracle-Gro price target raised to $300 from $290 at Raymond James
02/04/21 Truist
Scotts Miracle-Gro price target raised to $270 from $250 at Truist
SMG Scotts Miracle-Gro
$196.83 /

+2.465 (+1.27%)

SMG Scotts Miracle-Gro
$196.83 /

+2.465 (+1.27%)

Upgrade
Huntington Bancshares upgraded to Strong Buy from Outperform at Raymond James » 07:29
06/23/21
06/23
07:29
06/23/21
07:29
HBAN

Huntington Bancshares

$13.69 /

+0.01 (+0.07%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HBAN Huntington Bancshares
$13.69 /

+0.01 (+0.07%)

HBAN Huntington Bancshares
$13.69 /

+0.01 (+0.07%)

05:36 Today Raymond James
Huntington Bancshares upgraded to Strong Buy from Outperform at Raymond James
04/07/21 Barclays
Huntington Bancshares price target raised to $17 from $15 at Barclays
04/01/21 Deutsche Bank
Huntington Bancshares price target raised to $16 from $14 at Deutsche Bank
03/30/21 Stephens
Huntington Bancshares price target raised to $17.50 from $14 at Stephens
HBAN Huntington Bancshares
$13.69 /

+0.01 (+0.07%)

HBAN Huntington Bancshares
$13.69 /

+0.01 (+0.07%)

Recommendations
Gemini's negative stock reaction to GEM103 data overdone, says Stifel » 07:22
06/23/21
06/23
07:22
06/23/21
07:22
GMTX

Gemini Therapeutics

$9.81 /

-0.445 (-4.34%)

Stifel analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GMTX Gemini Therapeutics
$9.81 /

-0.445 (-4.34%)

GMTX Gemini Therapeutics
$9.81 /

-0.445 (-4.34%)

04/08/21 SVB Leerink
SVB Leerink bullish on Gemini Therapeutics, initiates with an Outperform
04/08/21 SVB Leerink
Gemini Therapeutics initiated with an Outperform at SVB Leerink
03/03/21 Jefferies
Gemini Therapeutics initiated with a Buy at Jefferies
03/02/21 Goldman Sachs
Gemini Therapeutics initiated with a Buy at Goldman Sachs
GMTX Gemini Therapeutics
$9.81 /

-0.445 (-4.34%)

GMTX Gemini Therapeutics
$9.81 /

-0.445 (-4.34%)

Recommendations
Score Media 'biggest winner' from C-218 passing, says Credit Suisse » 07:21
06/23/21
06/23
07:21
06/23/21
07:21
SCR

Score Media

$24.14 /

+1.78 (+7.96%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCR Score Media
$24.14 /

+1.78 (+7.96%)

06/22/21 Credit Suisse
Score Media rallies with Credit Suisse positive ahead of sports betting vote
03/23/21 Credit Suisse
Score Media initiated with an Outperform at Credit Suisse
03/22/21 Macquarie
Score Media initiated with an Outperform at Macquarie
  • 25
    Feb
SCR Score Media
$24.14 /

+1.78 (+7.96%)

SCR Score Media
$24.14 /

+1.78 (+7.96%)

SCR Score Media
$24.14 /

+1.78 (+7.96%)

General news
FX Update: The dollar ebbed back » 07:20
06/23/21
06/23
07:20
06/23/21
07:20
$ECON

Economic Data

/

+

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Recommendations
AeroVironment investors focus on upcoming results and potential, says Canaccord » 07:19
06/23/21
06/23
07:19
06/23/21
07:19
AVAV

AeroVironment

$112.10 /

+1.12 (+1.01%)

Canaccord analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVAV AeroVironment
$112.10 /

+1.12 (+1.01%)

AVAV AeroVironment
$112.10 /

+1.12 (+1.01%)

01/15/21 Stifel
AeroVironment downgraded to Hold from Buy at Stifel
01/14/21 Alembic Global
AeroVironment upgraded to Overweight from Neutral at Alembic Global
01/14/21 Baird
AeroVironment upgraded to Outperform after Arcturus deal at Baird
01/14/21 Baird
AeroVironment upgraded to Outperform from Neutral at Baird
AVAV AeroVironment
$112.10 /

+1.12 (+1.01%)

AVAV AeroVironment
$112.10 /

+1.12 (+1.01%)

Hot Stocks
Pebblebrook sees positive Q2 adjusted EBITDA , positive adjusted FFO in Q321 » 07:15
06/23/21
06/23
07:15
06/23/21
07:15
PEB

Pebblebrook Hotel

$23.39 /

-0.215 (-0.91%)

Pebblebrook Hotel Trust …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEB Pebblebrook Hotel
$23.39 /

-0.215 (-0.91%)

PEB Pebblebrook Hotel
$23.39 /

-0.215 (-0.91%)

06/14/21 Evercore ISI
Pebblebrook Hotel upgraded to In Line from Underperform at Evercore ISI
03/12/21 BTIG
Pebblebrook Hotel price target raised to $27 from $23 at BTIG
03/01/21 Compass Point
Compass Point more bullish on hotels, upgrades Pebblebrook to Buy
03/01/21 Compass Point
Pebblebrook Hotel upgraded to Buy from Neutral at Compass Point
PEB Pebblebrook Hotel
$23.39 /

-0.215 (-0.91%)

Recommendations
Motorsport Games news flow could begin mi-July, says Canaccord » 07:15
06/23/21
06/23
07:15
06/23/21
07:15
MSGM

Motorsport Games

$11.39 /

-0.305 (-2.61%)

Canaccord analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSGM Motorsport Games
$11.39 /

-0.305 (-2.61%)

MSGM Motorsport Games
$11.39 /

-0.305 (-2.61%)

03/25/21 Canaccord
Motorsport Games outlook in line with expectations, says Canaccord
03/16/21 Canaccord
Motorsport Games acquisition strengthens ties with NASCAR, says Canaccord
02/22/21 Canaccord
Motorsport Games portfolio strengthened with KartKraft buy, says Canaccord
02/08/21 Benchmark
Motorsport Games initiated with a Buy at Benchmark
  • 13
    Jan
MSGM Motorsport Games
$11.39 /

-0.305 (-2.61%)

Recommendations
Microsoft price target raised to $325 from $310 at Wedbush » 07:15
06/23/21
06/23
07:15
06/23/21
07:15
MSFT

Microsoft

$265.49 /

+2.89 (+1.10%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

06/16/21 William Blair
Microsoft gaming news opportunity not threat to Unity, says William Blair
06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
06/07/21 Morgan Stanley
Microsoft valuation presents 'attractive entry point,' says Morgan Stanley
06/03/21 Tigress Financial
Microsoft shares going to $303 in 12 months, says Tigress Financial
MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

MSFT Microsoft
$265.49 /

+2.89 (+1.10%)

Downgrade
Suruga Bank downgraded to Underweight from Neutral at JPMorgan » 07:14
06/23/21
06/23
07:14
06/23/21
07:14
SUGBY

Suruga Bank

$36.50 /

+ (+0.00%)

JPMorgan analyst Rie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Select Medical price target raised to $50 from $44 at Benchmark » 07:14
06/23/21
06/23
07:14
06/23/21
07:14
SEM

Select Medical

$41.63 /

-0.37 (-0.88%)

Benchmark analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEM Select Medical
$41.63 /

-0.37 (-0.88%)

SEM Select Medical
$41.63 /

-0.37 (-0.88%)

05/21/21 Deutsche Bank
Select Medical price target raised to $48 from $46 at Deutsche Bank
05/13/21 Benchmark
Select Medical price target raised to $44 from $40 at Benchmark
05/10/21 Deutsche Bank
Select Medical price target raised to $46 from $42 at Deutsche Bank
02/26/21 BofA
Select Medical upgraded to Buy from Underperform at BofA
SEM Select Medical
$41.63 /

-0.37 (-0.88%)

SEM Select Medical
$41.63 /

-0.37 (-0.88%)

Initiation
Vale Indonesia initiated with an Overweight at JPMorgan » 07:13
06/23/21
06/23
07:13
06/23/21
07:13
PTNDY

Vale Indonesia

/

+

JPMorgan analyst Benny…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Customers Bancorp price target raised to $51 from $42 at Wedbush » 07:13
06/23/21
06/23
07:13
06/23/21
07:13
CUBI

Customers Bancorp

$39.10 /

-0.595 (-1.50%)

Wedbush analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CUBI Customers Bancorp
$39.10 /

-0.595 (-1.50%)

CUBI Customers Bancorp
$39.10 /

-0.595 (-1.50%)

05/27/21 B. Riley
Customers Bancorp price target raised to $55 from $50 at B. Riley
04/30/21 Maxim
Customers Bancorp price target raised to $52 from $35 at Maxim
04/30/21 B. Riley
Customers Bancorp price target raised to $50 from $41 at B. Riley
03/31/21 B. Riley Securities
Customers Bancorp price target raised to $41 from $39 at B. Riley
CUBI Customers Bancorp
$39.10 /

-0.595 (-1.50%)

Recommendations
BioXcel Therapeutics price target lowered to $125 from $128 at Truist » 07:13
06/23/21
06/23
07:13
06/23/21
07:13
BTAI

BioXcel Therapeutics

$36.88 /

-1.38 (-3.61%)

Truist analyst Robyn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

06/01/21 H.C. Wainwright
BioXcel Therapeutics price target raised to $176 from $170 at H.C. Wainwright
05/11/21 H.C. Wainwright
BioXcel Therapeutics price target lowered to $170 from $175 at H.C. Wainwright
04/09/21 Berenberg
BioXcel Therapeutics initiated with a Buy at Berenberg
04/01/21 Truist
BioXcel Therapeutics price target lowered to $127 from $150 at Truist
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

  • 23
    Jun
  • 29
    Jul
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

Hot Stocks
Xebec Adsorption commissions on-site hydrogen generation system for TAYRAS » 07:12
06/23/21
06/23
07:12
06/23/21
07:12
XEBEF

Xebec Adsorption

$3.30 /

-0.0629 (-1.87%)

Xebec Adsorption announce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XEBEF Xebec Adsorption
$3.30 /

-0.0629 (-1.87%)

XEBEF Xebec Adsorption
$3.30 /

-0.0629 (-1.87%)

06/15/21 Canaccord
Xebec Adsorption price target raised to C$4.50 from C$4 at Canaccord
05/20/21 BMO Capital
Xebec Adsorption initiated with an Outperform at BMO Capital
05/14/21 Canaccord
Xebec Adsorption price target lowered to C$4 from C$4.50 at Canaccord
05/14/21 Stifel
Xebec Adsorption price target lowered to C$5 from C$5.60 at Stifel
XEBEF Xebec Adsorption
$3.30 /

-0.0629 (-1.87%)

Initiation
Aneka Tambang initiated with an Overweight at JPMorgan » 07:12
06/23/21
06/23
07:12
06/23/21
07:12
PAEKY

Aneka Tambang

$15.08 /

-3.39 (-18.35%)

JPMorgan analyst Benny…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
VBI Vaccines,Brii Bio present data on BRII-179 study for hepatitis B » 07:10
06/23/21
06/23
07:10
06/23/21
07:10
VBIV

VBI Vaccines

$3.90 /

+0.09 (+2.36%)

Brii Biosciences and VBI…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VBIV VBI Vaccines
$3.90 /

+0.09 (+2.36%)

VBIV VBI Vaccines
$3.90 /

+0.09 (+2.36%)

02/25/21 Jefferies
VBI Vaccines initiated with a Buy at Jefferies
08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
VBIV VBI Vaccines
$3.90 /

+0.09 (+2.36%)

VBIV VBI Vaccines
$3.90 /

+0.09 (+2.36%)

Hot Stocks
Calibre Mining publishes inaugural 2020 sustainability report » 07:10
06/23/21
06/23
07:10
06/23/21
07:10
CXBMF

Calibre Mining

$1.54 /

-0.0581 (-3.64%)

Calibre Mining announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CXBMF Calibre Mining
$1.54 /

-0.0581 (-3.64%)

CXBMF Calibre Mining
$1.54 /

-0.0581 (-3.64%)

04/06/21 Scotiabank
Calibre Mining price target lowered to C$2.75 from C$3 at Scotiabank
03/29/21 BMO Capital
Calibre Mining upgraded to Outperform from Market Perform at BMO Capital
01/14/21 BMO Capital
Calibre Mining initiated with a Market Perform at BMO Capital
10/13/20 Scotiabank
Calibre Mining price target raised to C$3 from C$2.75 at Scotiabank
Recommendations
Incyte's retifanlimab does not seem likely to be approved, says Benchmark » 07:10
06/23/21
06/23
07:10
06/23/21
07:10
INCY

Incyte

$85.07 /

+0.12 (+0.14%)

After the FDA published…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$85.07 /

+0.12 (+0.14%)

INCY Incyte
$85.07 /

+0.12 (+0.14%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
INCY Incyte
$85.07 /

+0.12 (+0.14%)

INCY Incyte
$85.07 /

+0.12 (+0.14%)

INCY Incyte
$85.07 /

+0.12 (+0.14%)

INCY Incyte
$85.07 /

+0.12 (+0.14%)

Hot Stocks
Gildan Activewear becomes member of U.S. Cotton Trust Protocol » 07:09
06/23/21
06/23
07:09
06/23/21
07:09
GIL

Gildan Activewear

$35.79 /

+1.05 (+3.02%)

The U.S. Cotton Trust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIL Gildan Activewear
$35.79 /

+1.05 (+3.02%)

GIL Gildan Activewear
$35.79 /

+1.05 (+3.02%)

04/21/21 TD Securities
Gildan Activewear price target raised to $38 from $36 at TD Securities
04/19/21 National Bank
Gildan Activewear price target raised to C$45 from C$43 at National Bank
04/07/21
Fly Intel: Top five analyst upgrades
04/07/21 UBS
Gildan Activewear upgraded to Buy with $43 target at UBS
GIL Gildan Activewear
$35.79 /

+1.05 (+3.02%)

GIL Gildan Activewear
$35.79 /

+1.05 (+3.02%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.